Global Operational Medicine 麻豆原创 Research Report 2023

Publication ID:

PB502230989

Publication Date:

February 15, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Operational medicine is the field of military medicine, providing medical and healthcare support to soldiers and their command systems in unconventional medical institutions. These treatments are provided under extremely difficult conditions and are of high severity. These treatment methods include providing first aid to wounded soldiers and helping to improve their survivability and minimize casualties.
Highlights
The global Operational Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Operational Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Operational Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Operational Medicine in Army is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Operational Medicine include Airbus Defense & Space, Boeing, China Aerospace Science and Industry Corporation, Israel Aerospace Industries, Lockheed Martin, Leonardo, MBDA, Northrop Grumman Corporation and Rafael Advanced Defense Systems, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Operational Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Operational Medicine.
The Operational Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Operational Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Operational Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Airbus Defense & Space
Boeing
China Aerospace Science and Industry Corporation
Israel Aerospace Industries
Lockheed Martin
Leonardo
MBDA
Northrop Grumman Corporation
Rafael Advanced Defense Systems
Raytheon
Rheinmetall AG
Saab
Thales
Segment by Type
Electronic Health Records
Telemedicine
Integrated Artificial Intelligence
Secured Health Data Infrastructure
Professional Services
Managed Services
Segment by Application
Army
Navy
Air Force and Space
麻豆原创land and Other Government Agencies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Operational Medicine companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Operational Medicine 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Electronic Health Records
1.2.3 Telemedicine
1.2.4 Integrated Artificial Intelligence
1.2.5 Secured Health Data Infrastructure
1.2.6 Professional Services
1.2.7 Managed Services
1.3 麻豆原创 by Application
1.3.1 Global Operational Medicine 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Army
1.3.3 Navy
1.3.4 Air Force and Space
1.3.5 麻豆原创land and Other Government Agencies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Operational Medicine 麻豆原创 Perspective (2018-2029)
2.2 Operational Medicine Growth Trends by Region
2.2.1 Global Operational Medicine 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Operational Medicine Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Operational Medicine Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Operational Medicine 麻豆原创 Dynamics
2.3.1 Operational Medicine Industry Trends
2.3.2 Operational Medicine 麻豆原创 Drivers
2.3.3 Operational Medicine 麻豆原创 Challenges
2.3.4 Operational Medicine 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Operational Medicine Players by Revenue
3.1.1 Global Top Operational Medicine Players by Revenue (2018-2023)
3.1.2 Global Operational Medicine Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Operational Medicine 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Operational Medicine Revenue
3.4 Global Operational Medicine 麻豆原创 Concentration Ratio
3.4.1 Global Operational Medicine 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Operational Medicine Revenue in 2022
3.5 Operational Medicine Key Players Head office and Area Served
3.6 Key Players Operational Medicine Product Solution and Service
3.7 Date of Enter into Operational Medicine 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Operational Medicine Breakdown Data by Type
4.1 Global Operational Medicine Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Operational Medicine Forecasted 麻豆原创 Size by Type (2024-2029)
5 Operational Medicine Breakdown Data by Application
5.1 Global Operational Medicine Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Operational Medicine Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Operational Medicine 麻豆原创 Size (2018-2029)
6.2 North America Operational Medicine 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Operational Medicine 麻豆原创 Size by Country (2018-2023)
6.4 North America Operational Medicine 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Operational Medicine 麻豆原创 Size (2018-2029)
7.2 Europe Operational Medicine 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Operational Medicine 麻豆原创 Size by Country (2018-2023)
7.4 Europe Operational Medicine 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Operational Medicine 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Operational Medicine 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Operational Medicine 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Operational Medicine 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Operational Medicine 麻豆原创 Size (2018-2029)
9.2 Latin America Operational Medicine 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Operational Medicine 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Operational Medicine 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Operational Medicine 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Operational Medicine 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Operational Medicine 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Operational Medicine 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Airbus Defense & Space
11.1.1 Airbus Defense & Space Company Detail
11.1.2 Airbus Defense & Space Business Overview
11.1.3 Airbus Defense & Space Operational Medicine Introduction
11.1.4 Airbus Defense & Space Revenue in Operational Medicine Business (2018-2023)
11.1.5 Airbus Defense & Space Recent Development
11.2 Boeing
11.2.1 Boeing Company Detail
11.2.2 Boeing Business Overview
11.2.3 Boeing Operational Medicine Introduction
11.2.4 Boeing Revenue in Operational Medicine Business (2018-2023)
11.2.5 Boeing Recent Development
11.3 China Aerospace Science and Industry Corporation
11.3.1 China Aerospace Science and Industry Corporation Company Detail
11.3.2 China Aerospace Science and Industry Corporation Business Overview
11.3.3 China Aerospace Science and Industry Corporation Operational Medicine Introduction
11.3.4 China Aerospace Science and Industry Corporation Revenue in Operational Medicine Business (2018-2023)
11.3.5 China Aerospace Science and Industry Corporation Recent Development
11.4 Israel Aerospace Industries
11.4.1 Israel Aerospace Industries Company Detail
11.4.2 Israel Aerospace Industries Business Overview
11.4.3 Israel Aerospace Industries Operational Medicine Introduction
11.4.4 Israel Aerospace Industries Revenue in Operational Medicine Business (2018-2023)
11.4.5 Israel Aerospace Industries Recent Development
11.5 Lockheed Martin
11.5.1 Lockheed Martin Company Detail
11.5.2 Lockheed Martin Business Overview
11.5.3 Lockheed Martin Operational Medicine Introduction
11.5.4 Lockheed Martin Revenue in Operational Medicine Business (2018-2023)
11.5.5 Lockheed Martin Recent Development
11.6 Leonardo
11.6.1 Leonardo Company Detail
11.6.2 Leonardo Business Overview
11.6.3 Leonardo Operational Medicine Introduction
11.6.4 Leonardo Revenue in Operational Medicine Business (2018-2023)
11.6.5 Leonardo Recent Development
11.7 MBDA
11.7.1 MBDA Company Detail
11.7.2 MBDA Business Overview
11.7.3 MBDA Operational Medicine Introduction
11.7.4 MBDA Revenue in Operational Medicine Business (2018-2023)
11.7.5 MBDA Recent Development
11.8 Northrop Grumman Corporation
11.8.1 Northrop Grumman Corporation Company Detail
11.8.2 Northrop Grumman Corporation Business Overview
11.8.3 Northrop Grumman Corporation Operational Medicine Introduction
11.8.4 Northrop Grumman Corporation Revenue in Operational Medicine Business (2018-2023)
11.8.5 Northrop Grumman Corporation Recent Development
11.9 Rafael Advanced Defense Systems
11.9.1 Rafael Advanced Defense Systems Company Detail
11.9.2 Rafael Advanced Defense Systems Business Overview
11.9.3 Rafael Advanced Defense Systems Operational Medicine Introduction
11.9.4 Rafael Advanced Defense Systems Revenue in Operational Medicine Business (2018-2023)
11.9.5 Rafael Advanced Defense Systems Recent Development
11.10 Raytheon
11.10.1 Raytheon Company Detail
11.10.2 Raytheon Business Overview
11.10.3 Raytheon Operational Medicine Introduction
11.10.4 Raytheon Revenue in Operational Medicine Business (2018-2023)
11.10.5 Raytheon Recent Development
11.11 Rheinmetall AG
11.11.1 Rheinmetall AG Company Detail
11.11.2 Rheinmetall AG Business Overview
11.11.3 Rheinmetall AG Operational Medicine Introduction
11.11.4 Rheinmetall AG Revenue in Operational Medicine Business (2018-2023)
11.11.5 Rheinmetall AG Recent Development
11.12 Saab
11.12.1 Saab Company Detail
11.12.2 Saab Business Overview
11.12.3 Saab Operational Medicine Introduction
11.12.4 Saab Revenue in Operational Medicine Business (2018-2023)
11.12.5 Saab Recent Development
11.13 Thales
11.13.1 Thales Company Detail
11.13.2 Thales Business Overview
11.13.3 Thales Operational Medicine Introduction
11.13.4 Thales Revenue in Operational Medicine Business (2018-2023)
11.13.5 Thales Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Airbus Defense & Space
Boeing
China Aerospace Science and Industry Corporation
Israel Aerospace Industries
Lockheed Martin
Leonardo
MBDA
Northrop Grumman Corporation
Rafael Advanced Defense Systems
Raytheon
Rheinmetall AG
Saab
Thales

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.